Search Results

You are looking at 131 - 140 of 1,187 items for :

  • glucocorticoids x
  • Refine by access: All content x
Clear All
G. C. LIGGINS
Search for other papers by G. C. LIGGINS in
Google Scholar
PubMed
Close

SUMMARY

Dexamethasone caused premature delivery when infused into foetal lambs at rates of 0·06–4·0 mg./24 hr. but it had no effect when administered to pregnant ewes at the rate of 4·0 mg./24 hr. Infusions into the foetus of deoxycorticosterone or corticosterone were ineffective; mixtures of dexamethasone and deoxycorticosterone did not cause parturition more rapidly than dexamethasone alone. Thus, the ability of corticosteroids to cause premature parturition appears to depend on glucocorticoid rather than mineralocorticoid activity.

Parturition induced by dexamethasone was not delayed by administration of 100 mg. progesterone/24 hr. to the ewe or to the foetus. This suggests either that withdrawal of inhibitory effects of progesterone on the myometrium can occur independently of the progesterone concentration in peripheral plasma, or that the mechanism of parturition provoked by corticosteroids in the foetus can override any regulatory influence of progesterone on myometrial contractility.

Partial aeration of the lungs was observed in lambs born vaginally at 117–123 days of gestation after receiving dexamethasone. It is suggested that this may be the result of accelerated appearance of surfactant activity.

Restricted access
Kenneth Smith
Search for other papers by Kenneth Smith in
Google Scholar
PubMed
Close
,
Sam Shuster
Search for other papers by Sam Shuster in
Google Scholar
PubMed
Close
, and
Michael Rawlins
Search for other papers by Michael Rawlins in
Google Scholar
PubMed
Close

Using an exchange assay to measure occupied and unoccupied binding sites the interaction between [3H]triamcinolone acetonide and rat skin cytosol proteins was studied. A binding site with a high affinity (dissociation constant = 7 × 10−10 mol/l) and a low capacity (400–600 fmol/mg protein) for triamcinolone acetonide was detected. The binding was specific to corticosteroids; fluorinated steroids showed a higher affinity than natural steroids. Non-corticosteroids, with the exception of progesterone, had little or no affinity for the binding site. At 0 °C the second-order rate constant of association was 2·23 × 106 mol/l per min and the first-order rate constant of dissociation was 1·6 × 10−4 per min. In the absence of dithiothreitol and molybdate the specific binding was rapidly abolished. The binding was also labile to heating and proteolytic enzymes. One day after adrenalectomy there was a significant increase in the number of assayable binding sites in the cytosol. The results are consistent with the binding protein being the physiological glucocorticoid receptor in rat skin.

Restricted access
JACQUELINE PORTHÉ-NIBELLE
Search for other papers by JACQUELINE PORTHÉ-NIBELLE in
Google Scholar
PubMed
Close
and
BRAHIM LAHLOU
Search for other papers by BRAHIM LAHLOU in
Google Scholar
PubMed
Close

Cytosols prepared from the liver and various tissues of goldfish (intact or hypophysectomized) and trout (intact) were incubated at 2 °C in the presence of tritiated cortisol or dexamethasone (3 × 10−9 to 3 × 10−6 mol/l) with or without a 1000-fold excess of unlabelled steroid. In contrast to mammals, the specifically bound component represented a very low fraction of the total bound steroid retained on DEAE cellulose filters and did not show saturation over a large range of concentrations.

The subcellular distribution of [3H]dexamethasone was studied in trout liver after intravascular injection of the labelled steroid with and without an excess of unlabelled steroid.

The amount of protein-bound steroid in the cytosol again corresponded to a small (4%) proportion of the free steroid. The large reduction in the uptake of tritiated dexamethasone, which was induced in both the cytosol and nuclei by competing unlabelled dexamethasone, was interpreted as evidence for mediated entry across cellular and nuclear membranes.

These results indicate that high-affinity binding sites are absent, or present only in very small numbers in cytosol from teleost tissues. The entry of glucocorticoids into the nucleus may not require the hormone to be bound to high-affinity cytosolic receptors unless the binding, though quantitatively small, displays a high rate of turnover.

Restricted access
M Karin
Search for other papers by M Karin in
Google Scholar
PubMed
Close
and
L Chang
Search for other papers by L Chang in
Google Scholar
PubMed
Close

More than a decade ago our view of gene regulation by glucocorticoids (GC) and other steroid hormones underwent a dramatic change with the discovery of negative crosstalk (transcriptional interference) between the GC receptor (GCR) and transcription factor AP-1 (Jun:Fos). It was initially observed that induction of the collagenase type 1 gene, which is mediated through activation of AP-1 by growth factors and inflammatory cytokines, is repressed by GC. This repression was attributed to mutual negative interactions between AP-1 and GCR. Although the exact molecular mechanism underlying this particular case of transcriptional interference is yet to be determined, it has become clear that this and analogous interactions with other transcription factors (e.g. nuclear factor-kappaB) underlie the anti-inflammatory and immunosuppressive activity of GC. Recent studies conducted at the whole animal level indicate that the interactions between the AP-1 and GC signaling pathways are much more extensive. AP-1-related signaling via the Jun N-terminal kinases can lead to increased levels of circulating GC, which eventually down-modulate AP-1 activity via transcriptional interference. This negative feedback loop is likely to be of great importance for maintenance of homeostasis and regulation of stress responses, including acute and chronic inflammation.

Free access
S R Valentini
Search for other papers by S R Valentini in
Google Scholar
PubMed
Close
and
M C S Armelin
Search for other papers by M C S Armelin in
Google Scholar
PubMed
Close

Abstract

The C6 rat glioma cell line is responsive to glucocorticoid hormones. C6 variants that are hyper-responsive (ST1) and resistant (P7) to hormone treatment have been derived previously. Glucocorticoid treatment of ST1 cells leads to complete reversion of the transformed phenotype and loss of tumorigenic potential. Production of C type retrovirus particles is also induced by glucocorticoids in ST1 cells. Cloning of the genes regulated by glucocorticoids in this cell system was used here as a strategy to uncover the gene products involved in the transformed-to-normal phenotypic change. Construction of a cDNA library from glucocorticoid-treated ST1 cells and screening by differential hybridization resulted in the isolation of three cellular sequences that code for rat metallothioneins (C27 and C41) and α1-acid glycoprotein (C36). Northern blot analysis revealed that expression of these genes was dramatically induced by hydrocortisone in ST1 but not in P7 cells. Viral genomic RNA was used to isolate and characterize retrovirus-related sequences that could also be responsible for the phenotypic reversion phenomenon.

Journal of Endocrinology (1996) 148, 11–17

Restricted access
Zhen Yang
Search for other papers by Zhen Yang in
Google Scholar
PubMed
Close
,
Chunming Guo
Search for other papers by Chunming Guo in
Google Scholar
PubMed
Close
,
Ping Zhu
Search for other papers by Ping Zhu in
Google Scholar
PubMed
Close
,
Wenjiao Li
Search for other papers by Wenjiao Li in
Google Scholar
PubMed
Close
,
Leslie Myatt
Search for other papers by Leslie Myatt in
Google Scholar
PubMed
Close
, and
Kang Sun
Search for other papers by Kang Sun in
Google Scholar
PubMed
Close

Introduction The amount of cortisol available to glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) is largely dependent upon the pre-receptor enzyme 11β-hydroxy-steroid dehydrogenase (11β-HSD; Seckl 1993 , Draper

Free access
A. J. Bradley
Search for other papers by A. J. Bradley in
Google Scholar
PubMed
Close
and
D. M. Stoddart
Search for other papers by D. M. Stoddart in
Google Scholar
PubMed
Close

ABSTRACT

An investigation spanning two breeding seasons was carried out to examine endocrine changes associated with reproduction in a wild population of the marsupial sugar glider Petaurus breviceps, a small arboreal gliding possum.

Using techniques of equilibrium dialysis and polyacrylamide gel electrophoresis at steady-state conditions, a high-affinity, low-capacity glucocorticoid-binding protein was demonstrated in the plasma of Petaurus breviceps.

Equilibrium dialysis at 36 °C using cortisol gave a high-affinity binding constant of 95 ± 5·2 litres/μmol for a presumed corticosteroid-binding globulin (CBG) while the binding constant for the cortisol-albumin interaction was 3·5 ± 0·4 litres/mmol.

There was no difference between the sexes in the affinity of binding of cortisol to CBG; however, the cortisol-binding capacity underwent seasonal variation in both sexes. Progesterone was bound strongly to the presumed CBG while neither oestradiol nor aldosterone appeared to be bound with high affinity to P. breviceps plasma.

In the males, peaks in the plasma concentration of testosterone coincided with the July–September breeding season in both years. A significant inverse relationship was shown to exist between the plasma testosterone concentration and the CBG-binding capacity.

In both sexes an increase occurred in the plasma concentration of free cortisol during the first breeding season, a pattern which was not repeated in the subsequent breeding season, possibly due to a lower population density in that year.

Journal of Endocrinology (1992) 132, 21–31

Restricted access
K. Smith
Search for other papers by K. Smith in
Google Scholar
PubMed
Close
and
S. Shuster
Search for other papers by S. Shuster in
Google Scholar
PubMed
Close

ABSTRACT

Using an exchange assay to measure occupied and unoccupied binding sites, the glucocorticoid receptor in rat skin cytosol has been measured after adrenalectomy and parenteral steroid administration. Adrenalectomy increased the number of receptor sites with maximal effect after 5 days, after which numbers decreased to those of intact animals. Injection of adrenalectomized animals with the unlabelled agonist corticosterone resulted in a rapid dose-related decrease in the number of cytosolic receptor sites at 30 min whereas the antagonist progesterone had no effect. It is concluded that changes in glucocorticoid concentration lead to rapid inverse changes in cytosolic receptor.

J. Endocr. (1984) 102, 161–165

Restricted access
DM Sloboda
Search for other papers by DM Sloboda in
Google Scholar
PubMed
Close
,
JP Newnham
Search for other papers by JP Newnham in
Google Scholar
PubMed
Close
, and
Challis JR
Search for other papers by Challis JR in
Google Scholar
PubMed
Close

Prenatal glucocorticoid exposure has been associated with a reduction in birth weight and postnatal alterations in glucose homeostasis and hypothalamic-pituitary-adrenal (HPA) axis function. The mechanisms underlying these responses are unknown, although changes in fetal hepatic development may play an important role. The fetal liver produces key regulators of fuel metabolism and of the developing HPA axis that are altered by glucocorticoids. The local availability of glucocorticoids is regulated, in part, by corticosteroid-binding protein (CBG), glucocorticoid receptors (GR) and by the enzyme 11beta-hydroxysteroid dehydrogenase (11betaHSD), but the effects of maternal glucocorticoid administration on the expression of these genes in the fetal liver are unknown. 11betaHSD1 is the predominant form of this enzyme present in the liver and is responsible for the conversion of cortisone to cortisol. To determine if prenatal glucocorticoid exposure alters fetal hepatic regulation of CBG, 11betaHSD1 and GRs, we treated pregnant ewes with betamethasone (0.5 mg/kg) intramuscularly at 104, 111 and 118 days of gestation (term 150 days). Animals were killed at 125 or 146 days of gestation. Maternal betamethasone administration did not alter mean cord plasma glucose but significantly decreased cord plasma insulin levels (P<0.05) at 125 days of gestation. At 146 days of gestation, cord plasma glucose levels were significantly increased without alterations in insulin levels following maternal betamethasone treatment (P<0.05). Maternal betamethasone administration resulted in a significant increase in fetal hepatic 11betaHSD1 mRNA and protein levels at 125 days of gestation (P<0.05). CBG mRNA levels were significantly elevated over control at 125 days although levels of CBG protein were not significantly different. GR protein levels were not statistically different at either 125 or 146 days of gestation following glucocorticoid administration. These data suggest that prenatal betamethasone exposure in the ovine fetus results in alterations in cord glucose and insulin levels as well as alterations in hepatic 11betaHSD1 mRNA and protein expression. These changes in 11betaHSD1 increase the potential to generate local cortisol from circulating cortisone. We speculate that this could affect expression of glucocorticoid-dependent hepatic enzymes involved with the regulation of glucose production and HPA responsiveness.

Free access
NO Vidal
Search for other papers by NO Vidal in
Google Scholar
PubMed
Close
,
H Brandstrom
Search for other papers by H Brandstrom in
Google Scholar
PubMed
Close
,
KB Jonsson
Search for other papers by KB Jonsson in
Google Scholar
PubMed
Close
, and
C Ohlsson
Search for other papers by C Ohlsson in
Google Scholar
PubMed
Close

Osteoprotegerin (OPG) is a recently cloned member of the tumour necrosis factor receptor family. It has been suggested that this secreted glycoprotein acts as an inhibitor of osteoclastic differentiation. Expression of OPG has previously been demonstrated in a number of tissues. However, it is still unclear whether or not OPG is expressed by human osteoblasts. We have used the RNase protection assay to demonstrate the OPG transcript in primary cultured human osteoblast-like cells, human marrow stroma cells and osteosarcoma cell lines. Furthermore, we have studied the effect of glucocorticoids on OPG mRNA levels in these cells. We demonstrate that glucocorticoids decrease the OPG transcript in a dose- and time-dependent manner. The time-course study reveals that hydrocortisone (10(-6) M) decreases OPG mRNA levels within 2 h. This decrease is transient, reaching control levels again after 24 h. Our findings demonstrate that human osteoblasts express the mRNA corresponding to OPG, an inhibitor of osteoclast differentiation. The finding that OPG mRNA levels are decreased by glucocorticoids indicates that a reduced production of OPG from osteoblasts and/or marrow stroma cells could, in part, explain glucocorticoid-induced bone resorption.

Free access